|
Immune CB1 Activation for Obesity Therapy
Reference #: 01478
The University of South Carolina is offering licensing opportunities for Immune CB1 activation for obesity therapy
Background:
The endocannabinoid system regulates various physiological processes such as inflammation and metabolism, and is comprised of cannabinoid receptors, CB1 and CB2, as well as their ligands called endocannabinoids....
Published: 6/11/2026
|
Updated: 5/7/2021
|
Inventor(s): Prakash Nagarkatti, Mitzi Nagarkatti, Kathryn Miranda
Keywords(s): anti-inflammatory pharma, cannabinoids, CB1, inflammation, metabolic syndrome, Obesity, weight loss
Category(s): Health Sciences, Biomedical and Life Sciences
|